These results indicate that the lncRNA SNHG12 regulates radiosensitivity of cervical cancer through the SNHG12/miR-148a/CDK1 regulatory axis and provides a new therapeutic target for the radiosensitivity of cervical cancer. Here, CDK1 is linked to cervical cancer.